AQST Q2 2020 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

Q2 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$22M+94.8% YoY

Gross Profit

$18M83.7% margin

Operating Income

$395,0001.8% margin

Net Income

-$2M-10.8% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+147.3%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$64M

Total Liabilities

$85M

Stockholders' Equity

-$21M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$11M	+94.8%
Gross Profit	$18M	$6M	+217.7%
Operating Income	$395,000	-$19M	+102.1%
Net Income	-$2M	-$20M	+88.6%

Revenue Segments

License and Royalty Revenue

$13M64%

Manufacture and Supply Revenue

$7M36%